Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-22

Clinical Trial Update: A Local Clinical Study for the Comparative Evaluation of Efficacy and Safety of Angal, Lozenges [Menthol] and ANTI-ANGIN® FORMULA, Lozenges, in Treatment of Patients With a Sore Throat [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing Angal lozenges with ANTI-ANGIN lozenges for sore throat; study completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ANTI-ANGIN® FORMULA, Lozenges (ANTI-ANGIN)
  • Angal Lozenges [Menthol] (Angal)

Snippet

Sponsor: Sandoz | Conditions: Sore Throat | Phase 3 | Status: COMPLETED | Results posted: 2019-03-22